Olanzapine Versus Placebo in the Treatment of Mania in Adolescents With Bipolar I Disorder

Completed · Phase 4 · Has a placebo group

Conditions studied: Bipolar Disorder

In brief

The purpose of this study is to determine the efficacy (how well the drug works), safety, and any side effects of olanzapine compared to placebo in the treatment of mania in bipolar disorder in adolescents. Both the potential benefits and side effects of olanzapine will be evaluated throughout this trial.

Key facts

Study ID
NCT00050206
Run by
Eli Lilly and Company
People needed
130
Starts
2002-11-01
Expected to finish
2005-05-01
Last updated by the study team
2007-06-12

Who can join

Age: 13 and older, up to 17. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.